$ELTP
ELITE PHARMACEUTICALS INC /NV/ Stock $eltp

$eltp Overview Financials Valuation SEC Filings Company Website

2016 Q1 Form 10-K Financial Statement

#000114420416108327 Filed on June 15, 2016

Income Statement

Concept	2016 Q1	2016	2015 Q1
Revenue	$5.195M	$12.50M	$1.234M
YoY Change	320.99%	149.21%	20.04%
Cost Of Revenue	$1.036M	$4.484M	$904.0K
YoY Change	14.6%	48.8%	-13.58%
Gross Profit	$4.159M	$8.014M	$331.0K
YoY Change	1156.5%	300.38%	-1938.89%
Gross Profit Margin	80.06%	64.12%	26.82%
Selling, General & Admin		$3.237M
YoY Change		2.29%
% of Gross Profit		40.39%
Research & Development		$12.43M
YoY Change		-15.61%
% of Gross Profit		155.09%
Depreciation & Amortization	$180.0K	$666.5K	-$70.00K
YoY Change	-357.14%	14.54%	-158.33%
% of Gross Profit	4.33%	8.32%	-21.15%
Operating Expenses	$3.588M	$16.33M	$5.788M
YoY Change	-38.01%	-11.77%	144.74%
Operating Profit	$571.0K	-$8.317M	-$5.457M
YoY Change	-110.46%	-49.62%	128.9%
Interest Expense		$280.7K
YoY Change		-2.28%
% of Operating Profit
Other Income/Expense, Net	$7.408M	$7.113M	-$898.0K
YoY Change	-924.94%	-67.26%	-97.16%
Pretax Income		-$1.203M
YoY Change		-123.07%
Income Tax	-$520.0K	-$520.5K	-$3.000K
% Of Pretax Income
Net Earnings	$8.499M	-$683.0K	-$6.350M
YoY Change	-233.84%	-113.08%	-92.68%
Net Earnings / Revenue	163.6%	-5.46%	-514.59%
Basic Earnings Per Share	$0.03	-$0.01	-$0.01
Diluted Earnings Per Share	$0.00	-$0.01	-$0.01
COMMON SHARES
Basic Shares Outstanding	695.2M shares	673.9M shares
Diluted Shares Outstanding		673.9M shares

Balance Sheet

Concept	2016 Q1	2016	2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.51M	$11.51M	$7.460M
YoY Change	54.29%	54.23%	7.49%
Cash & Equivalents	$11.51M		$7.464M
Short-Term Investments
Other Short-Term Assets	$380.0K	$377.8K	$390.0K
YoY Change	-2.56%	-2.66%	21.88%
Inventory	$3.294M	$3.294M	$3.032M
Prepaid Expenses
Receivables	$1.530M	$1.530M	$1.446M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$16.71M	$16.71M	$12.33M
YoY Change	35.55%	35.55%	24.24%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.111M	$8.111M	$6.402M
YoY Change	26.69%	26.69%	52.44%
Goodwill
YoY Change
Intangibles	$6.412M		$6.382M
YoY Change	0.47%		0.5%
Long-Term Investments	$50.00K	$48.71K	$200.0K
YoY Change	-75.0%	-75.46%	-94.03%
Other Assets	$437.7K	$389.0K	$806.0K
YoY Change	-45.7%	-35.98%	-79.03%
Total Long-Term Assets	$14.96M	$14.96M	$13.59M
YoY Change	10.09%	10.09%	-5.58%
TOTAL ASSETS
Total Short-Term Assets	$16.71M	$16.71M	$12.33M
Total Long-Term Assets	$14.96M	$14.96M	$13.59M
Total Assets	$31.67M	$31.67M	$25.92M
YoY Change	22.2%	22.2%	6.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.804M	$1.804M	$3.384M
YoY Change	-46.67%	-54.86%	53.1%
Accrued Expenses	$555.4K	$555.4K	$614.0K
YoY Change	-9.55%
Deferred Revenue
YoY Change
Short-Term Debt	$34.68K	$718.3K	$0.00
YoY Change		23.19%	-100.0%
Long-Term Debt Due	$308.3K	$548.8K	$265.2K
YoY Change	16.25%	15.49%	202.79%
Total Short-Term Liabilities	$4.640M	$4.640M	$5.069M
YoY Change	-8.46%	-8.46%	-17.72%
LONG-TERM LIABILITIES
Long-Term Debt	$2.180M	$2.176M	$2.070M
YoY Change	5.31%	5.36%	10869.79%
Other Long-Term Liabilities	$47.42K	$13.69M	$629.1K
YoY Change	-92.46%	-26.04%	379.73%
Total Long-Term Liabilities	$15.87M	$15.87M	$20.58M
YoY Change	-22.89%	-22.89%	-79.28%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.640M	$4.640M	$5.069M
Total Long-Term Liabilities	$15.87M	$15.87M	$20.58M
Total Liabilities	$20.51M	$20.51M	$25.65M
YoY Change	-20.04%	-20.04%	-75.69%
SHAREHOLDERS EQUITY
Retained Earnings	-$142.7M		-$142.0M
YoY Change	0.48%		-36.9%
Common Stock	$109.8M		$107.6M
YoY Change	2.13%		-25.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$306.8K		$306.8K
YoY Change	0.0%		0.0%
Treasury Stock Shares	100.0K shares		100.0K shares
Shareholders Equity	-$33.12M	$11.16M	-$34.73M
YoY Change
Total Liabilities & Shareholders Equity	$31.67M	$31.67M	$25.92M
YoY Change	22.2%	22.2%	6.59%

Cashflow Statement

Concept	2016 Q1	2016	2015 Q1
OPERATING ACTIVITIES
Net Income	$8.499M	-$683.0K	-$6.350M
YoY Change	-233.84%	-113.08%	-92.68%
Depreciation, Depletion And Amortization	$180.0K	$666.5K	-$70.00K
YoY Change	-357.14%	14.54%	-158.33%
Cash From Operating Activities	$600.0K	-$2.765M	-$3.850M
YoY Change	-115.58%	-81.69%	160.14%
INVESTING ACTIVITIES
Capital Expenditures	-$570.0K	-$1.949M	-$600.0K
YoY Change	-5.0%	-2.41%	361.54%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities	-$570.0K	-$1.949M	-$600.0K
YoY Change	-5.0%	-167.69%	757.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$6.200M
YoY Change		-53.16%
Debt Paid & Issued, Net		$210.0K
YoY Change		-81.08%
Cash From Financing Activities	3.370M	$8.762M	3.650M
YoY Change	-7.67%	-31.26%	-50.68%
NET CHANGE
Cash From Operating Activities	600.0K	-$2.765M	-3.850M
Cash From Investing Activities	-570.0K	-$1.949M	-600.0K
Cash From Financing Activities	3.370M	$8.762M	3.650M
Net Change In Cash	3.400M	$4.048M	-800.0K
YoY Change	-525.0%	674.88%	-113.68%
FREE CASH FLOW
Cash From Operating Activities	$600.0K	-$2.765M	-$3.850M
Capital Expenditures	-$570.0K	-$1.949M	-$600.0K
Free Cash Flow	$1.170M	-$816.6K	-$3.250M
YoY Change	-136.0%	-93.77%	140.74%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8110721	USD
CY2016Q1	us-gaap	Stockholders Equity StockholdersEquity	-33122237	USD
CY2016Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	109137805	USD
CY2016Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	16060705	USD
CY2015Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25920279	USD
CY2016Q1	us-gaap	Liabilities Liabilities	20715072	USD
CY2016Q1	us-gaap	Common Stock Value CommonStockValue	711546	USD
CY2015Q1	us-gaap	Common Stock Value CommonStockValue	631162	USD
CY2015Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	106926328	USD
CY2016Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-142664747	USD
CY2016Q1	us-gaap	Treasury Stock Value TreasuryStockValue	306841	USD
CY2016Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31878550	USD
CY2016Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6411799	USD
CY2015Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts	218579	USD
CY2015Q1	us-gaap	Assets Assets	25920279	USD
CY2015Q1	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	583071	USD
CY2016Q1	us-gaap	Secured Long Term Debt SecuredLongTermDebt	1845000	USD
CY2015Q1	us-gaap	Secured Long Term Debt SecuredLongTermDebt	2065000	USD
CY2016	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2016	dei	Entity Registrant Name EntityRegistrantName	ELITE PHARMACEUTICALS INC /NV/
CY2016	dei	Entity Central Index Key EntityCentralIndexKey	0001053369
CY2016	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2016	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2016	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2015Q3	dei	Entity Public Float EntityPublicFloat	156803944	USD
CY2016	dei	Trading Symbol TradingSymbol	ELTP
CY2015Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6401802	USD
CY2015Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6381774	USD
CY2016Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts	204401	USD
CY2016Q1	us-gaap	Assets Assets	31878550	USD
CY2016Q1	us-gaap	Secured Debt Current SecuredDebtCurrent	220000	USD
CY2016Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	308263	USD
CY2015Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	265165	USD
CY2016Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1804429	USD
CY2015Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3383533	USD
CY2015Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5069097	USD
CY2016Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	44285715	USD
CY2015Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	35000000	USD
CY2014	us-gaap	Revenue Other Manufactured Products RevenueOtherManufacturedProducts	2982400	USD
CY2014	us-gaap	Sales Revenue Net SalesRevenueNet	4601376	USD
CY2014	us-gaap	Cost Of Revenue CostOfRevenue	3236106	USD
CY2014	us-gaap	Gross Profit GrossProfit	1365270	USD
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3959316	USD
CY2014	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2105725	USD
CY2014	us-gaap	Operating Expenses OperatingExpenses	6648894	USD
CY2014	us-gaap	License And Services Revenue LicenseAndServicesRevenue	1536039	USD
CY2014	us-gaap	Contracts Revenue ContractsRevenue	82937	USD
CY2016Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	726486650	shares
CY2016	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2015Q1	us-gaap	Security Deposit SecurityDeposit	198481	USD
CY2016Q1	us-gaap	Security Deposit SecurityDeposit	48714	USD
CY2015Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	388959	USD
CY2016Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	642074	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7464180	USD
CY2015Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	806019	USD
CY2014	us-gaap	Depreciation And Amortization DepreciationAndAmortization	500906	USD
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	82947	USD
CY2016Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	388959	USD
CY2016Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1530296	USD
CY2015Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1446441	USD
CY2016Q1	us-gaap	Inventory Net InventoryNet	3293729	USD
CY2015Q1	us-gaap	Inventory Net InventoryNet	3032002	USD
CY2016Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	377752	USD
CY2015Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	388061	USD
CY2016Q1	us-gaap	Assets Current AssetsCurrent	16713956	USD
CY2015Q1	us-gaap	Assets Current AssetsCurrent	12330684	USD
CY2015Q1	us-gaap	Secured Debt Current SecuredDebtCurrent	210000	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	-5283624	USD
CY2014	us-gaap	Interest Expense InterestExpense	859328	USD
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	757579152	shares
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	591214959	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	673905485	shares
CY2016Q1	us-gaap	Liabilities Current LiabilitiesCurrent	4654367	USD
CY2015Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	629138	USD
CY2015	us-gaap	Sales Revenue Net SalesRevenueNet	5015246	USD
CY2016Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	568251	USD
CY2016	us-gaap	Sales Revenue Net SalesRevenueNet	12498332	USD
CY2015	us-gaap	Cost Of Revenue CostOfRevenue	3013592	USD
CY2016	us-gaap	Cost Of Revenue CostOfRevenue	4484162	USD
CY2015	us-gaap	Gross Profit GrossProfit	2001654	USD
CY2015Q1	us-gaap	Stockholders Equity StockholdersEquity	-34731086	USD
CY2015Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	20582268	USD
CY2015Q1	us-gaap	Liabilities Liabilities	25651365	USD
CY2015Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-141981735	USD
CY2015Q1	us-gaap	Treasury Stock Value TreasuryStockValue	306841	USD
CY2014	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	58178	USD
CY2015	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	21724328	USD
CY2015	us-gaap	Interest Expense InterestExpense	287231	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	5220605	USD
CY2014	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	1515	USD
CY2014	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	19831	USD
CY2014	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-36269884	USD
CY2014	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-96575271	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-41260897	USD
CY2014	eltp	Change In Fair Value Of Warrant Derivatives ChangeInFairValueOfWarrantDerivatives	-35389799	USD
CY2014	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	0	USD
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	463021991	shares
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	463021991	shares
CY2015	us-gaap	Revenue Other Manufactured Products RevenueOtherManufacturedProducts	3870457	USD
CY2016	us-gaap	Revenue Other Manufactured Products RevenueOtherManufacturedProducts	8002866	USD
CY2015	us-gaap	License And Services Revenue LicenseAndServicesRevenue	1139789	USD
CY2016	us-gaap	License And Services Revenue LicenseAndServicesRevenue	4495466	USD
CY2015	us-gaap	Contracts Revenue ContractsRevenue	5000	USD
CY2016	us-gaap	Contracts Revenue ContractsRevenue	0	USD
CY2016	us-gaap	Gross Profit GrossProfit	8014170	USD
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14727472	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12428783	USD
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2904114	USD
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2903178	USD
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	260045	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	333362	USD
CY2015	us-gaap	Depreciation And Amortization DepreciationAndAmortization	616995	USD
CY2016	us-gaap	Depreciation And Amortization DepreciationAndAmortization	665647	USD
CY2015	us-gaap	Operating Expenses OperatingExpenses	18508626	USD
CY2016	us-gaap	Operating Expenses OperatingExpenses	16330970	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	-16506972	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-8316800	USD
CY2016	us-gaap	Interest Expense InterestExpense	280670	USD
CY2015	eltp	Change In Fair Value Of Warrant Derivatives ChangeInFairValueOfWarrantDerivatives	20340874	USD
CY2016	eltp	Change In Fair Value Of Warrant Derivatives ChangeInFairValueOfWarrantDerivatives	7394006	USD
CY2015	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	1670685	USD
CY2016	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	0	USD
CY2015	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2016	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2016	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7113336	USD
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	28929674	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9968727	USD
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	673905485	shares
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-683012	USD
CY2016	eltp	Change In Value Of Convertible Preferred Share Mezzanine Equity ChangeInValueOfConvertiblePreferredShareMezzanineEquity	-9285715	USD
CY2015	eltp	Change In Value Of Convertible Preferred Share Mezzanine Equity ChangeInValueOfConvertiblePreferredShareMezzanineEquity	23709069	USD
CY2014	eltp	Change In Value Of Convertible Preferred Share Mezzanine Equity ChangeInValueOfConvertiblePreferredShareMezzanineEquity	-55314374	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	666461	USD
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	581855	USD
CY2016	eltp	Accrued Compensation Non Cash AccruedCompensationNonCash	573667	USD
CY2015	eltp	Accrued Compensation Non Cash AccruedCompensationNonCash	679771	USD
CY2016	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	333363	USD
CY2015	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	260047	USD
CY2016	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-22996	USD
CY2015	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	23703	USD
CY2016	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	1621	USD
CY2015	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	1526	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-33240	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	714355	USD
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	261727	USD
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1099518	USD
CY2016	eltp	Increase Decrease In Prepaid And Other Current Assets IncreaseDecreaseInPrepaidAndOtherCurrentAssets	-160076	USD
CY2015	eltp	Increase Decrease In Prepaid And Other Current Assets IncreaseDecreaseInPrepaidAndOtherCurrentAssets	147188	USD
CY2016	eltp	Milestone Issued For Epic Strategic Alliance Agreement Value MilestoneIssuedForEpicStrategicAllianceAgreementValue	840000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2211414	USD
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	453746	USD
CY2014	eltp	Accrued Compensation Non Cash AccruedCompensationNonCash	95000	USD
CY2014	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	82947	USD
CY2014	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-49439	USD
CY2014	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	1438	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1131477	USD
CY2016	eltp	Increase Decrease In Deferred Revenue And Customer Deposits IncreaseDecreaseInDeferredRevenueAndCustomerDeposits	4153330	USD
CY2015	eltp	Increase Decrease In Deferred Revenue And Customer Deposits IncreaseDecreaseInDeferredRevenueAndCustomerDeposits	-13333	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2765421	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-15103233	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1948829	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	2879213	USD
CY2016	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	1918804	USD
CY2015	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	1965018	USD
CY2016	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	30025	USD
CY2015	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	31853	USD
CY2015	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	123916	USD
CY2015	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	5000000	USD
CY2016	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3041499	USD
CY2015	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	800853	USD
CY2016	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	404131	USD
CY2015	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	219010	USD
CY2015	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	16365	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	8762249	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	12746424	USD
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	4047999	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	522404	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6941776	USD
CY2016	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	210000	USD
CY2015	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1110000	USD
CY2016	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	117095	USD
CY2015	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	0	USD
CY2016	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2016	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	0	USD
CY2016	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2015	eltp	Milestone Issued For Epic Strategic Alliance Agreement Value MilestoneIssuedForEpicStrategicAllianceAgreementValue	0	USD
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	66922	USD
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	574340	USD
CY2014	eltp	Increase Decrease In Prepaid And Other Current Assets IncreaseDecreaseInPrepaidAndOtherCurrentAssets	169373	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	788445	USD
CY2014	eltp	Increase Decrease In Deferred Revenue And Customer Deposits IncreaseDecreaseInDeferredRevenueAndCustomerDeposits	-13333	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-4216876	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-557669	USD
CY2014	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	502268	USD
CY2014	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-2777	USD
CY2014	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	0	USD
CY2014	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	868051	USD
CY2014	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	47987	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	11347299	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	6572754	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	369023	USD
CY2014	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2014	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	0	USD
CY2014	eltp	Milestone Issued For Epic Strategic Alliance Agreement Value MilestoneIssuedForEpicStrategicAllianceAgreementValue	0	USD
CY2016	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6199643	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	333363	USD
CY2016	eltp	Stock Issued During Period Value Execution Of Warrants StockIssuedDuringPeriodValueExecutionOfWarrants	3017748	USD
CY2016	eltp	Park Capital Purchase Agreement ParkCapitalPurchaseAgreement	84102	USD
CY2016	eltp	Stock Issued During Period Value Payment Of Directors Fees StockIssuedDuringPeriodValuePaymentOfDirectorsFees	100071	USD
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	23751	USD
CY2016	eltp	Milestone Issued Value For Epic Strategic Alliance Agreement MilestoneIssuedValueForEpicStrategicAllianceAgreement	840000	USD
CY2015	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	13236624	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	260047	USD
CY2015	eltp	Stock Issued During Period Value Execution Of Warrants StockIssuedDuringPeriodValueExecutionOfWarrants	774853	USD
CY2015	eltp	Park Capital Purchase Agreement ParkCapitalPurchaseAgreement	0	USD
CY2015	eltp	Stock Issued During Period Value Payment Of Directors Fees StockIssuedDuringPeriodValuePaymentOfDirectorsFees	110000	USD
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	26000	USD
CY2013Q1	us-gaap	Stockholders Equity StockholdersEquity	-8673388	USD
CY2014	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10000000	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	82947	USD
CY2014Q1	us-gaap	Stockholders Equity StockholdersEquity	-81198155	USD
CY2014	eltp	Stock Issued During Period Value Execution Of Warrants StockIssuedDuringPeriodValueExecutionOfWarrants	3601020	USD
CY2014	eltp	Park Capital Purchase Agreement ParkCapitalPurchaseAgreement	0	USD
CY2014	eltp	Stock Issued During Period Value Payment Of Directors Fees StockIssuedDuringPeriodValuePaymentOfDirectorsFees	110000	USD
CY2014	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	24300	USD
CY2016Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	2845246	USD
CY2015Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	2850459	USD
CY2016Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	222784	USD
CY2015Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	58770	USD
CY2016Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	225699	USD
CY2015Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	122773	USD
CY2016	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	30025	USD
CY2014Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6349919	USD
CY2015	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	31855	USD
CY2016Q1	eltp	Derivative Liability Warrants DerivativeLiabilityWarrants	10368567	USD
CY2015Q1	eltp	Derivative Liability Warrants DerivativeLiabilityWarrants	17762573	USD
CY2016Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3278887	USD
CY2015Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	125557	USD
CY2016Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1013333	USD
CY2015Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	13333	USD
CY2016	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px 0px 0px 0.9in; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="COLOR: black"><u>USE OF ESTIMATES</u></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px 0px 0px 0.9in; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="COLOR: black">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made by management include, but are not limited to, the recognition of revenue, the amount of the allowance for doubtful accounts receivable and the fair value of intangible assets, stock-based awards and derivatives.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	272620	USD
CY2015Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6074117	USD
CY2016Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6726401	USD
CY2016Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2016Q1	eltp	Accumulated Amortization Eda Bond Offering Costs AccumulatedAmortizationEdaBondOfferingCosts	150052	USD
CY2015Q1	eltp	Accumulated Amortization Eda Bond Offering Costs AccumulatedAmortizationEdaBondOfferingCosts	135874	USD
CY2016Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	995000000	shares
CY2015Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	690000000	shares
CY2016Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	711544352	shares
CY2015Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	631160701	shares
CY2016Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	711444352	shares
CY2015Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	631060701	shares
CY2016Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	100000	shares
CY2015Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	100000	shares
CY2016	us-gaap	Property Plant And Equipment Depreciation Methods PropertyPlantAndEquipmentDepreciationMethods	straight-line method
CY2016	us-gaap	Finite Lived Intangible Assets Amortization Method FiniteLivedIntangibleAssetsAmortizationMethod	straight-line method
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1203464	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5217356	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-41553508	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-520452	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3249	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-292611	USD
CY2016Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	11500000	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	47987	USD
CY2014	eltp	Stockissuedduringperiodvaluepaymentofemployeesalaries Stockissuedduringperiodvaluepaymentofemployeesalaries	368233	USD
CY2014	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	18836	USD
CY2014	eltp	Stock Issued During Period Value Payment For Preferred Share Derivative Interest StockIssuedDuringPeriodValuePaymentForPreferredShareDerivativeInterest	68089	USD
CY2014	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	9825066	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	16365	USD
CY2015	eltp	Stockissuedduringperiodvaluepaymentofemployeesalaries Stockissuedduringperiodvaluepaymentofemployeesalaries	849737	USD
CY2015	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	23999	USD
CY2014	us-gaap	Interest Paid InterestPaid	289494	USD
CY2015	eltp	Conversionofseriesbseriescandseriesepreferredsharesintocommonsharesvalue Conversionofseriesbseriescandseriesepreferredsharesintocommonsharesvalue	2272500	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	84102	USD
CY2016	eltp	Stockissuedduringperiodvaluepaymentofemployeesalaries Stockissuedduringperiodvaluepaymentofemployeesalaries	1039000	USD
CY2016	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	24000	USD
CY2016	eltp	Interest Expense Non Cash InterestExpenseNonCash	0	USD
CY2015	eltp	Interest Expense Non Cash InterestExpenseNonCash	0	USD
CY2014	eltp	Interest Expense Non Cash InterestExpenseNonCash	568395	USD
CY2016	eltp	Stock Option Plan Expense1 StockOptionPlanExpense1	24000	USD
CY2015	eltp	Stock Option Plan Expense1 StockOptionPlanExpense1	23999	USD
CY2014	eltp	Stock Option Plan Expense1 StockOptionPlanExpense1	18836	USD
CY2016	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1139071	USD
CY2015	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	959737	USD
CY2014	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	478233	USD
CY2016	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	135238	USD
CY2015	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	54322	USD
CY2014	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	528750	USD
CY2016	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6199643	USD
CY2015	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	13236624	USD
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10000000	USD
CY2016	eltp	Increase Decrease In Derivative Interest Payable Net IncreaseDecreaseInDerivativeInterestPayableNet	0	USD
CY2015	eltp	Increase Decrease In Derivative Interest Payable Net IncreaseDecreaseInDerivativeInterestPayableNet	0	USD
CY2014	eltp	Increase Decrease In Derivative Interest Payable Net IncreaseDecreaseInDerivativeInterestPayableNet	-27500	USD
CY2016	us-gaap	Paid In Kind Interest PaidInKindInterest	0	USD
CY2014	us-gaap	Paid In Kind Interest PaidInKindInterest	68089	USD
CY2016	us-gaap	Interest Paid InterestPaid	215878	USD
CY2015	us-gaap	Interest Paid InterestPaid	89336	USD
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	4048	USD
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	2500	USD
CY2014	us-gaap	Income Taxes Paid IncomeTaxesPaid	3099	USD
CY2015	eltp	Commitment Shares Issued CommitmentSharesIssued	830521	USD
CY2014	eltp	Commitment Shares Issued CommitmentSharesIssued	1112838	USD
CY2016	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	USD
CY2015	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	2272500	USD
CY2014	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	9825066	USD
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	0	USD
CY2015	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	0	USD
CY2014	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	5597317	USD
CY2016	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
CY2015	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
CY2014	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	600000	USD
CY2016	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2015	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2014	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	7953591	USD
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	442399	USD
CY2015	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	804861	USD
CY2014	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	107960	USD
CY2016Q1	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Redemption Value RedeemableNoncontrollingInterestEquityPreferredRedemptionValue	-9285715	USD
CY2015Q1	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Redemption Value RedeemableNoncontrollingInterestEquityPreferredRedemptionValue	23709069	USD
CY2014Q1	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Redemption Value RedeemableNoncontrollingInterestEquityPreferredRedemptionValue	55314374	USD
CY2015	us-gaap	Depreciation Depreciation	652284	USD
CY2014	us-gaap	Depreciation Depreciation	566028	USD
CY2016	us-gaap	Revenue Recognition Milestone Method Milestone RevenueRecognitionMilestoneMethodMilestone	The milestones, totaling $500k, consist of amounts due upon the first shipment of each identified product, as follows: Phentermine 37.5mg tablets ($145k), Phentermine 15 &amp; 30mg capsules ($45k), Hydromorphone 8mg ($125k), Naltrexone 50mg ($95k) and the balance of $95k due in relation to the first shipment of generic products which still require marketing authorizations from the FDA, and to which there can be no assurances of such marketing authorizations being granted and accordingly there can be no assurances that the Company will earn and receive these milestone amounts.
CY2016Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	14837122	USD
CY2015Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12475919	USD
CY2014Q2	us-gaap	Cost Method Investments CostMethodInvestments	3329322	USD
CY2014Q2	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	1670685	USD
CY2015Q1	eltp	Bond Issue Costs BondIssueCosts	354453	USD
CY2016Q1	eltp	Bond Issue Costs BondIssueCosts	354453	USD
CY2015Q1	eltp	Accumulated Amortization Of Bond AccumulatedAmortizationOfBond	135874	USD
CY2016Q1	eltp	Accumulated Amortization Of Bond AccumulatedAmortizationOfBond	150052	USD
CY2015Q1	eltp	Unamortization Of Bond UnamortizationOfBond	218579	USD
CY2016Q1	eltp	Unamortization Of Bond UnamortizationOfBond	204401	USD
CY2016Q1	eltp	Equipment Financing Payable Current EquipmentFinancingPayableCurrent	342945	USD
CY2015Q1	eltp	Equipment Financing Payable Current EquipmentFinancingPayableCurrent	265165	USD
CY2016Q1	eltp	Equipment Financing Payable Non Current EquipmentFinancingPayableNonCurrent	-520827	USD
CY2015Q1	eltp	Equipment Financing Payable Non Current EquipmentFinancingPayableNonCurrent	-560338	USD
CY2016Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	19528	USD
CY2015Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	42524	USD
CY2016Q1	eltp	Lease Termination Costs Current LeaseTerminationCostsCurrent	0	USD
CY2015Q1	eltp	Lease Termination Costs Current LeaseTerminationCostsCurrent	0	USD
CY2016Q1	eltp	Lease Termination Costs Non Current LeaseTerminationCostsNonCurrent	27896	USD
CY2015Q1	eltp	Lease Termination Costs Non Current LeaseTerminationCostsNonCurrent	26275	USD
CY2016Q1	eltp	Short Term Loans And Current Portion Of Long Term Debt ShortTermLoansAndCurrentPortionOfLongTermDebt	342945	USD
CY2015Q1	eltp	Short Term Loans And Current Portion Of Long Term Debt ShortTermLoansAndCurrentPortionOfLongTermDebt	265165	USD
CY2016Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	442399	USD
CY2015Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	909477	USD
CY2016	us-gaap	Debt Instrument Interest Rate Stated Percentage Rate Range Minimum DebtInstrumentInterestRateStatedPercentageRateRangeMinimum	0.068	pure
CY2016	us-gaap	Debt Instrument Interest Rate Stated Percentage Rate Range Maximum DebtInstrumentInterestRateStatedPercentageRateRangeMaximum	0.122	pure
CY2016	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2016-12-31
CY2016	eltp	Lease Renewal Term LeaseRenewalTerm	P5Y
CY2015	eltp	Interest Expenses Derivatives InterestExpensesDerivatives	0	USD
CY2014	eltp	Interest Expenses Derivatives InterestExpensesDerivatives	40588	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2014	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-4048000	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-3248000	USD
CY2014	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-3099000	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2014	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	524500000	USD
CY2015	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	0	USD
CY2014	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	295710000	USD
CY2016	us-gaap	Income Tax Credits And Adjustments IncomeTaxCreditsAndAdjustments	520452000	USD
CY2015	us-gaap	Income Tax Credits And Adjustments IncomeTaxCreditsAndAdjustments	-3248000	USD
CY2014	us-gaap	Income Tax Credits And Adjustments IncomeTaxCreditsAndAdjustments	292611000	USD
CY2016Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	27033000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	24547000	USD
CY2014Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	19813000	USD
CY2016Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	27033000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	24547000	USD
CY2014Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	19813000	USD
CY2016	eltp	Interest Expenses Derivatives InterestExpensesDerivatives	0	USD
CY2016Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2015Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2014Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7642167	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5435667	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.48
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.54
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	360000	shares
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2590000	shares
CY2016	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	112500	shares
CY2015	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	223334	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	280000	shares
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	160166	shares
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7609667	shares
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.48
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.60
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.18
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.21
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.12
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.38
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.31
CY2015	us-gaap	Paid In Kind Interest PaidInKindInterest	0	USD
CY2016Q1	eltp	Lease Termination Cost Payable LeaseTerminationCostPayable	50000	USD
CY2016Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	0	USD
CY2016Q1	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	0	USD
CY2016Q1	us-gaap	Deferred Revenue DeferredRevenue	4292220	USD
CY2016	eltp	Corporate Unallocated Costs CorporateUnallocatedCosts	1772241	USD
CY2015	eltp	Corporate Unallocated Costs CorporateUnallocatedCosts	1319939	USD
CY2014	eltp	Corporate Unallocated Costs CorporateUnallocatedCosts	1351921	USD
CY2016	us-gaap	Investment Income Interest InvestmentIncomeInterest	9802	USD
CY2015	us-gaap	Investment Income Interest InvestmentIncomeInterest	7	USD
CY2014	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	USD
CY2016	us-gaap	Other Noncash Expense OtherNoncashExpense	1513433	USD
CY2015	us-gaap	Other Noncash Expense OtherNoncashExpense	1281052	USD
CY2014	us-gaap	Other Noncash Expense OtherNoncashExpense	749935	USD
CY2016	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	7394006	USD
CY2015	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	20340874	USD
CY2014	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-35430386	USD
CY2015Q1	eltp	Warrants Outstanding WarrantsOutstanding	89870034	shares
CY2014Q1	eltp	Warrants Outstanding WarrantsOutstanding	102143091	shares
CY2016Q1	eltp	Warrants Outstanding Weighted Average Exercise Price WarrantsOutstandingWeightedAverageExercisePrice	0.06
CY2015Q1	eltp	Warrants Outstanding Weighted Average Exercise Price WarrantsOutstandingWeightedAverageExercisePrice	0.06
CY2016Q1	eltp	Warrants Outstanding WarrantsOutstanding	41586066	shares
CY2014Q1	eltp	Warrants Outstanding Weighted Average Exercise Price WarrantsOutstandingWeightedAverageExercisePrice	0.06
CY2016	eltp	Warrant Exercised Forfeitures And Expirations During Period WarrantExercisedForfeituresAndExpirationsDuringPeriod	48283968	shares
CY2015	eltp	Warrant Exercised Forfeitures And Expirations During Period WarrantExercisedForfeituresAndExpirationsDuringPeriod	12273057	shares
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	153430	USD
CY2016	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	180854	USD
CY2016	eltp	Warrant Exercised Forfeitures And Expirations During Period Weighted Average Exercise Price WarrantExercisedForfeituresAndExpirationsDuringPeriodWeightedAverageExercisePrice	0.06
CY2015	eltp	Warrant Exercised Forfeitures And Expirations During Period Weighted Average Exercise Price WarrantExercisedForfeituresAndExpirationsDuringPeriodWeightedAverageExercisePrice	0.07
CY2016	eltp	Operating Lease Description OperatingLeaseDescription	6 years with 2 tenant renewal options for 5 years each
CY2016Q1	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	155169	USD
CY2016Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	0	USD
CY2016Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	0	USD
CY2016Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	359019	USD
CY2016	eltp	Lease Initiation Date LeaseInitiationDate	2010-07-01
CY2016	eltp	Actual Lease Payments ActualLeasePayments	203850	USD
CY2015	eltp	Actual Lease Payments ActualLeasePayments	114321	USD
CY2016	eltp	Straight Line Deferred Rent Liability Adjustments StraightLineDeferredRentLiabilityAdjustments	0	USD
CY2015	eltp	Straight Line Deferred Rent Liability Adjustments StraightLineDeferredRentLiabilityAdjustments	-15409	USD
CY2016Q1	us-gaap	Deferred Rent Credit DeferredRentCredit	19528	USD
CY2015Q1	us-gaap	Deferred Rent Credit DeferredRentCredit	42524	USD
CY2016	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	100071	USD
CY2015	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	110000	USD
CY2014	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	110000	USD
CY2016	us-gaap	Officers Compensation OfficersCompensation	1039000	USD
CY2015	us-gaap	Officers Compensation OfficersCompensation	849737	USD
CY2014	us-gaap	Officers Compensation OfficersCompensation	368233	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3000000	shares
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.07
CY2014	eltp	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Grant Date Fair Value ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue	202497	USD
CY2016Q1	eltp	Common Stock Traded Percent CommonStockTradedPercent	0.3	pure
CY2016Q1	eltp	Common Stock Weighted Average Price Percent CommonStockWeightedAveragePricePercent	0.97	pure
CY2015	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	142857143	shares
CY2015	eltp	Incremental Common Shares Attributable To Warrant IncrementalCommonSharesAttributableToWarrant	22926029	shares
CY2015	eltp	Incremental Common Shares Attributable To Stock Options IncrementalCommonSharesAttributableToStockOptions	581020	shares
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	5595066	shares
CY2016	us-gaap	Valuation Allowance Commentary ValuationAllowanceCommentary	At March 31, 2016 and 2015, a 100% valuation allowance is provided
CY2016	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	10000000	USD
CY2016Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.07
CY2016	us-gaap	Debt Instrument Convertible Number Of Equity Instruments DebtInstrumentConvertibleNumberOfEquityInstruments	14286	pure
CY2016	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	1000	USD
CY2016Q1	us-gaap	Sales Revenue Net SalesRevenueNet	5195000	USD
CY2015Q4	us-gaap	Sales Revenue Net SalesRevenueNet	2194000	USD
CY2015Q3	us-gaap	Sales Revenue Net SalesRevenueNet	2947000	USD
CY2015Q2	us-gaap	Sales Revenue Net SalesRevenueNet	2163000	USD
CY2016Q1	us-gaap	Cost Of Revenue CostOfRevenue	1036000	USD
CY2015Q4	us-gaap	Cost Of Revenue CostOfRevenue	836000	USD
CY2015Q3	us-gaap	Cost Of Revenue CostOfRevenue	1415000	USD
CY2015Q2	us-gaap	Cost Of Revenue CostOfRevenue	1197000	USD
CY2016Q1	us-gaap	Gross Profit GrossProfit	4159000	USD
CY2015Q4	us-gaap	Gross Profit GrossProfit	1358000	USD
CY2015Q3	us-gaap	Gross Profit GrossProfit	1532000	USD
CY2015Q2	us-gaap	Gross Profit GrossProfit	966000	USD
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	3588000	USD
CY2015Q4	us-gaap	Operating Expenses OperatingExpenses	4071000	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	5299000	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	3373000	USD
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	571000	USD
CY2015Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-2713000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3767000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2407000	USD
CY2016Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7408000	USD
CY2015Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9520000	USD
CY2015Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2086000	USD
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7139000	USD
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-520000	USD
CY2015Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016Q1	us-gaap	Profit Loss ProfitLoss	8499000	USD
CY2015Q4	us-gaap	Profit Loss ProfitLoss	-12233000	USD
CY2015Q3	us-gaap	Profit Loss ProfitLoss	-1681000	USD
CY2015Q2	us-gaap	Profit Loss ProfitLoss	4732000	USD
CY2016Q1	eltp	Change In Value Of Convertible Preferred Share Mezzanine Equity ChangeInValueOfConvertiblePreferredShareMezzanineEquity	14142000	USD
CY2015Q4	eltp	Change In Value Of Convertible Preferred Share Mezzanine Equity ChangeInValueOfConvertiblePreferredShareMezzanineEquity	-24786000	USD
CY2015Q3	eltp	Change In Value Of Convertible Preferred Share Mezzanine Equity ChangeInValueOfConvertiblePreferredShareMezzanineEquity	-5071000	USD
CY2015Q2	eltp	Change In Value Of Convertible Preferred Share Mezzanine Equity ChangeInValueOfConvertiblePreferredShareMezzanineEquity	6429000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	22641000	USD
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	-37019000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-6753000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	11161000	USD
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2015Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2015Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2015Q1	us-gaap	Sales Revenue Net SalesRevenueNet	1234000	USD
CY2014Q4	us-gaap	Sales Revenue Net SalesRevenueNet	1363000	USD
CY2014Q3	us-gaap	Sales Revenue Net SalesRevenueNet	1256000	USD
CY2014Q4	us-gaap	Profit Loss ProfitLoss	7417000	USD
CY2014Q3	us-gaap	Profit Loss ProfitLoss	6248000	USD
CY2015Q1	us-gaap	Profit Loss ProfitLoss	-6350000	USD
CY2014Q2	us-gaap	Sales Revenue Net SalesRevenueNet	1162000	USD
CY2015Q1	us-gaap	Cost Of Revenue CostOfRevenue	904000	USD
CY2014Q4	us-gaap	Cost Of Revenue CostOfRevenue	700000	USD
CY2014Q3	us-gaap	Cost Of Revenue CostOfRevenue	682000	USD
CY2014Q2	us-gaap	Cost Of Revenue CostOfRevenue	729000	USD
CY2015Q1	us-gaap	Gross Profit GrossProfit	331000	USD
CY2014Q4	us-gaap	Gross Profit GrossProfit	663000	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	575000	USD
CY2014Q2	us-gaap	Gross Profit GrossProfit	433000	USD
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	5788000	USD
CY2014Q4	us-gaap	Operating Expenses OperatingExpenses	3221000	USD
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	4636000	USD
CY2014Q2	us-gaap	Operating Expenses OperatingExpenses	4864000	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5457000	USD
CY2014Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-2557000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4061000	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4431000	USD
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-898000	USD
CY2014Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	9974000	USD
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	10310000	USD
CY2014Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2338000	USD
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3000	USD
CY2014Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2014Q2	us-gaap	Profit Loss ProfitLoss	-2094000	USD
CY2015Q1	eltp	Change In Value Of Convertible Preferred Share Mezzanine Equity ChangeInValueOfConvertiblePreferredShareMezzanineEquity	-2715000	USD
CY2014Q4	eltp	Change In Value Of Convertible Preferred Share Mezzanine Equity ChangeInValueOfConvertiblePreferredShareMezzanineEquity	13600000	USD
CY2014Q3	eltp	Change In Value Of Convertible Preferred Share Mezzanine Equity ChangeInValueOfConvertiblePreferredShareMezzanineEquity	15132000	USD
CY2014Q2	eltp	Change In Value Of Convertible Preferred Share Mezzanine Equity ChangeInValueOfConvertiblePreferredShareMezzanineEquity	-2308000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-9065000	USD
CY2014Q4	us-gaap	Net Income Loss NetIncomeLoss	21017000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	21380000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-4402000	USD
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2014Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2014Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2014Q1	us-gaap	Sales Revenue Net SalesRevenueNet	1028000	USD
CY2013Q4	us-gaap	Sales Revenue Net SalesRevenueNet	1693000	USD
CY2013Q3	us-gaap	Sales Revenue Net SalesRevenueNet	1159000	USD
CY2013Q2	us-gaap	Sales Revenue Net SalesRevenueNet	722000	USD
CY2014Q1	us-gaap	Cost Of Revenue CostOfRevenue	1046000	USD
CY2013Q4	us-gaap	Cost Of Revenue CostOfRevenue	995000	USD
CY2013Q3	us-gaap	Cost Of Revenue CostOfRevenue	617000	USD
CY2013Q2	us-gaap	Cost Of Revenue CostOfRevenue	579000	USD
CY2014Q1	us-gaap	Gross Profit GrossProfit	-18000	USD
CY2014Q1	us-gaap	Profit Loss ProfitLoss	-33741000	USD
CY2013Q4	us-gaap	Profit Loss ProfitLoss	-1061000	USD
CY2013Q3	us-gaap	Profit Loss ProfitLoss	-7576000	USD
CY2013Q2	us-gaap	Profit Loss ProfitLoss	1119000	USD
CY2014Q1	eltp	Change In Value Of Convertible Preferred Share Mezzanine Equity ChangeInValueOfConvertiblePreferredShareMezzanineEquity	-53056000	USD
CY2013Q4	eltp	Change In Value Of Convertible Preferred Share Mezzanine Equity ChangeInValueOfConvertiblePreferredShareMezzanineEquity	1000	USD
CY2013Q3	eltp	Change In Value Of Convertible Preferred Share Mezzanine Equity ChangeInValueOfConvertiblePreferredShareMezzanineEquity	-2061000	USD
CY2013Q2	eltp	Change In Value Of Convertible Preferred Share Mezzanine Equity ChangeInValueOfConvertiblePreferredShareMezzanineEquity	-197000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-86798000	USD
CY2013Q4	us-gaap	Gross Profit GrossProfit	699000	USD
CY2013Q3	us-gaap	Gross Profit GrossProfit	542000	USD
CY2013Q2	us-gaap	Gross Profit GrossProfit	143000	USD
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	2365000	USD
CY2013Q4	us-gaap	Operating Expenses OperatingExpenses	1936000	USD
CY2013Q3	us-gaap	Operating Expenses OperatingExpenses	1229000	USD
CY2013Q2	us-gaap	Operating Expenses OperatingExpenses	1118000	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2384000	USD
CY2013Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-1237000	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-687000	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-976000	USD
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-31652000	USD
CY2013Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	175000	USD
CY2013Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6887000	USD
CY2013Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2095000	USD
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-295000	USD
CY2013Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2013Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	USD
CY2013Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	-1062000	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-9638000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	922000	USD
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2013Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2013Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2016	eltp	Derivative Liability Warrants Exercise Price DerivativeLiabilityWarrantsExercisePrice	0.0625
CY2015	eltp	Derivative Liability Warrants Exercise Price DerivativeLiabilityWarrantsExercisePrice	0.25
CY2016Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	0	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	0	USD
CY2016Q1	eltp	Dividend Distribution Rights Issue Redemption Price Per Right DividendDistributionRightsIssueRedemptionPricePerRight	0.000001
CY2014	eltp	Conversionofseriesbseriescandseriesepreferredsharesintocommonsharesvalue Conversionofseriesbseriescandseriesepreferredsharesintocommonsharesvalue	9825066	USD
CY2015	eltp	Stock Issued During Period Value Payment For Preferred Share Derivative Interest StockIssuedDuringPeriodValuePaymentForPreferredShareDerivativeInterest	0	USD
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.08
CY2016	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px 0px 0px 0.9in; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px 0px 0px 0.9in; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="COLOR: black"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>CONCENTRATION OF CREDIT RISK</u></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px 0px 0px 0.9in; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="COLOR: black">The Company maintains cash balances, which, at times, may exceed the amounts insured by the Federal Deposit Insurance Corp. Uninsured balances at March 31, 2016 are $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">11.5</font> million. Management does not believe that there is any significant risk of losses.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px 0px 0px 0.9in; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="COLOR: black"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px 0px 0px 0.9in; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="COLOR: black">The Company in the normal course of business extends credit to its customers based on contract terms and performs ongoing credit evaluations. An allowance for doubtful accounts due to uncertainty of collection is established based on historical collection experience. Amounts are written off when payment is not received after exhaustive collection efforts. During Fiscal 2016, Fiscal 2015 and Fiscal 2014, the Company generated all its revenues from six, seven and ten companies, respectively. The termination of the contracts with either of such companies will result in the loss of a significant amount of revenues currently being earned.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q2	us-gaap	Proceeds From Divestiture Of Interest In Joint Venture ProceedsFromDivestitureOfInterestInJointVenture	5000000	USD
CY2014Q1	eltp	Derivative Liability Warrants DerivativeLiabilityWarrants	38103446	USD
CY2015	eltp	Derivative Liability Warrants Exercised In Period DerivativeLiabilityWarrantsExercisedInPeriod	2578300	USD
CY2015	eltp	Derivative Liability Warrants Change In Fair Value Of Warrant Liability DerivativeLiabilityWarrantsChangeInFairValueOfWarrantLiability	-18447573	USD
CY2016	eltp	Conversionofseriesbseriescandseriesepreferredsharesintocommonsharesvalue Conversionofseriesbseriescandseriesepreferredsharesintocommonsharesvalue	0	USD
CY2016Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	34681	USD
CY2015Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	0	USD
CY2016Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	555352	USD
CY2015Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	613995	USD
CY2016	eltp	Commitment Shares Issued CommitmentSharesIssued	84102	USD
CY2016	eltp	Derivative Liability Warrants Exercised In Period DerivativeLiabilityWarrantsExercisedInPeriod	14788012	USD
CY2016	eltp	Derivative Liability Warrants Change In Fair Value Of Warrant Liability DerivativeLiabilityWarrantsChangeInFairValueOfWarrantLiability	7394006	USD
CY2013Q1	eltp	Derivative Liability Warrants DerivativeLiabilityWarrants	7862848	USD
CY2014	eltp	Derivative Liability Warrants Exercised In Period DerivativeLiabilityWarrantsExercisedInPeriod	2757271	USD
CY2014	eltp	Derivative Liability Warrants Change In Fair Value Of Warrant Liability DerivativeLiabilityWarrantsChangeInFairValueOfWarrantLiability	32997869	USD
CY2016	eltp	Stock Issued During Period Value Payment For Preferred Share Derivative Interest StockIssuedDuringPeriodValuePaymentForPreferredShareDerivativeInterest	0	USD
CY2015	eltp	Reversal Of Change In Fair Value Of Warrant Derivatives ReversalOfChangeInFairValueOfWarrantDerivatives	18447573	USD
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3939000	shares
CY2014	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	308333	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	1195000	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.18
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	1.60
CY2015	eltp	Reversal Of Change In Fair Value Of Convertible Preferred Share Mezzanine Equity ReversalOfChangeInFairValueOfConvertiblePreferredShareMezzanineEquity	25602370	USD
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-15120269	USD
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.07
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.021	pure
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.022	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.022	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.028	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.025	pure
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.19	pure
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.2	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.2	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.21	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.3	pure
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0	pure
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0	pure
CY2016	eltp	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate	0.027	pure
CY2015	eltp	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate	0.0	pure
CY2014	eltp	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate	0.0	pure
CY2016Q1	us-gaap	Officers Compensation OfficersCompensation	207500	USD
CY2016	eltp	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Grant Date Fair Value ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue	129913	USD
CY2015	eltp	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Grant Date Fair Value ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue	769421	USD
CY2016	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; font-size-adjust: none; font-stretch: normal" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0.58in"> <div><font style="COLOR: black"><b>NOTE 28</b></font></div> </td> <td style="TEXT-ALIGN: center; WIDTH: 0.32in"> <div>-</div> </td> <td style="TEXT-ALIGN: justify"> <div><font style="COLOR: black"><b>CONTINGENCIES</b></font></div> </td> </tr> </table> <font style="COLOR: black"><b> </b></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px 0px 0px 0.9in; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="COLOR: black">As part of the Company’s efforts to ensure the retention and continuity of key employees, officers and directors in the event of a change of control of the ownership of the Company, the Board of Directors passed a resolution whereby, in the event of a change in control of the ownership of the Company, key executives would receive an amount equal to twelve months of such executive’s salary, and certain Directors and managers would receive an amount equal to six months of such Director’s or managers fees or salaries, as applicable. In addition, the resolution passed provided for the immediate vesting of outstanding options, in the event of a change of control.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	904409	USD
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	642981	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	22173	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	31513	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	101962	USD
CY2016Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	462308	USD
CY2016	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y

Files In Submission

Name	View Source	Status
0001144204-16-108327-index-headers.html	Edgar Link	pending
0001144204-16-108327-index.html	Edgar Link	pending
0001144204-16-108327.txt	Edgar Link	pending
0001144204-16-108327-xbrl.zip	Edgar Link	pending
eltp-20160331.xml	Edgar Link	completed
eltp-20160331.xsd	Edgar Link	pending
eltp-20160331_cal.xml	Edgar Link	unprocessable
eltp-20160331_def.xml	Edgar Link	unprocessable
eltp-20160331_lab.xml	Edgar Link	unprocessable
eltp-20160331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tpg55.jpg	Edgar Link	pending
v441688_10k.htm	Edgar Link	pending
v441688_ex21.htm	Edgar Link	pending
v441688_ex23-1.htm	Edgar Link	pending
v441688_ex23-2.htm	Edgar Link	pending
v441688_ex31-1.htm	Edgar Link	pending
v441688_ex31-2.htm	Edgar Link	pending
v441688_ex32-1.htm	Edgar Link	pending
v441688_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ELTP
ELITE PHARMACEUTICALS INC /NV/ Stock $eltp

2016 Q1 Form 10-K Financial Statement

#000114420416108327 Filed on June 15, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELTP ELITE PHARMACEUTICALS INC /NV/ Stock $eltp

2016 Q1 Form 10-K Financial Statement

#000114420416108327 Filed on June 15, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELTP
ELITE PHARMACEUTICALS INC /NV/ Stock $eltp